oxazolidin-2-one has been researched along with Infectious Skin Diseases in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (70.59) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Li, H; Li, Z; Lyu, C; Shen, J; Wang, X; Zhang, L | 1 |
Bouza, E; Burillo, A; Muñoz, P | 1 |
Corey, GR; Das, AF; De Anda, C; Fang, E; Lodise, TP; Prokocimer, P; Shorr, AF | 1 |
Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
Esposito, S; Leone, S; Noviello, S | 1 |
Besnier, JM; De Cock, E; Dupon, M; Duttagupta, S; Guery, B; Levrat, F; Sorensen, S | 1 |
Cuervo, J; Gil-Parrado, S; Grau, S; Rebollo, P | 1 |
Bruss, J; Fleishaker, D; Hilty, M; Naberhuis-Stehouwer, S; Tregnaghi, M; Wible, K | 1 |
Katta, R; Metry, D | 1 |
Scheinfeld, NS; Weinberg, JM | 1 |
Bodmann, KF | 1 |
Choi, SH; Gonzalez, G; Ochoa-Felix, EY; Tijerina, R; Vera-Cabrera, L; Welsh, O | 1 |
Polk, HC; Sharpe, JN; Shively, EH | 1 |
Itani, KM; Liu, LZ; McKinnon, PS; Sorensen, SV | 1 |
Peppard, WJ; Weigelt, JA | 1 |
Wilson, P | 1 |
8 review(s) available for oxazolidin-2-one and Infectious Skin Diseases
Article | Year |
---|---|
The role of tedizolid in skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Tetrazoles; Treatment Outcome | 2018 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
[Skin and soft tissue infections: current therapeutic options].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Daptomycin; Humans; Linezolid; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Tigecycline; Time Factors; Treatment Outcome | 2008 |
New and emerging pediatric infections.
Topics: Acetamides; Child; Drug Resistance, Multiple; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Skin Diseases, Infectious; Staphylococcal Infections | 2003 |
Cutaneous infections in the elderly: diagnosis and management.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Anti-Bacterial Agents; Antidepressive Agents, Tricyclic; Antiviral Agents; Famciclovir; Herpes Zoster; Humans; Itraconazole; Linezolid; Onychomycosis; Oxazolidinones; Skin Diseases, Infectious; Virginiamycin | 2003 |
[Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Infectious; Soft Tissue Infections | 2004 |
Role of linezolid in the treatment of complicated skin and soft tissue infections.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections | 2006 |
Linezolid: a new antibiotic for gram-positive infections.
Topics: Acetamides; Anti-Infective Agents; Drug Costs; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections | 2001 |
4 trial(s) available for oxazolidin-2-one and Infectious Skin Diseases
Article | Year |
---|---|
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Skin Diseases, Infectious; Staphylococcal Skin Infections; Tetrazoles | 2015 |
Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children.
Topics: Acetamides; Administration, Oral; Adolescent; Cefadroxil; Child; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Probability; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Skin Diseases, Infectious; Treatment Outcome | 2003 |
Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Administration, Oral; Adult; Aged; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin | 2005 |
Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Clinical Trials as Topic; Cost-Benefit Analysis; Delivery of Health Care; Drug Costs; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Prospective Studies; Regression Analysis; Skin Diseases, Infectious; Streptococcal Infections; Treatment Outcome; Vancomycin | 2006 |
5 other study(ies) available for oxazolidin-2-one and Infectious Skin Diseases
Article | Year |
---|---|
Clinical efficacy of psychiatric nursing-based vancomycin in the treatment of Staphylococcus aureus infectious skin diseases.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Psychiatric Nursing; Retrospective Studies; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2023 |
Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Decision Trees; Drug Monitoring; France; Gram-Positive Bacterial Infections; Humans; Inpatients; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections | 2009 |
[Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Data Interpretation, Statistical; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Oxazolidinones; Salvage Therapy; Skin Diseases, Infectious; Spain; Treatment Failure; Vancomycin; Young Adult | 2011 |
In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae.
Topics: Anti-Infective Agents; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxazolidinones; Quinolones; Skin Diseases, Infectious | 2004 |
Two new drugs join the war on superbugs.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Linezolid; Oxazolidinones; Pneumonia; Skin Diseases, Infectious; Vancomycin Resistance; Virginiamycin | 2000 |